Publications by authors named "M E B Rijnders"

Problem: Despite increasing interest in Group Care worldwide, implementation is challenging.

Background: Group Care is an evidence-based perinatal care model including three core components: health assessment, interactive learning, and community building. It has several advantages for service users and providers compared to individual perinatal care.

View Article and Find Full Text PDF

Background: By addressing physical and psychosocial needs, group care (GC) improves health-related behaviours, peer support, parent-provider interactions and may improve birth outcomes. Hence, global implementation of GC is encouraged. Context analyses prior to implementation are vital to elucidate which local factors may support or hinder implementation.

View Article and Find Full Text PDF

Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) enzymes mutate specific DNA sequences and hairpin-loop structures, challenging the distinction between passenger and driver hotspot mutations. Here, we characterized 115 whole genomes of metastatic urothelial carcinoma (mUC) to identify APOBEC mutagenic hotspot drivers. APOBEC-associated mutations were detected in 92% of mUCs and were equally distributed across the genome, while APOBEC hotspot mutations (ApoHMs) were enriched in open chromatin.

View Article and Find Full Text PDF

Introduction: Maintaining and enhancing vaccine confidence continues to be a challenge. Making an informed decision not only helps to avoid potential future regret but also reduces susceptibility to misinformation. There is an urgent need for interventions that facilitate informed decision-making about vaccines.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICI) enhance survival in metastatic urothelial cancer (mUC) patients, but response varies greatly among individuals.
  • Researchers analyzed DNA and RNA from tumors to find predictive markers for treatment response, discovering that tumor mutational burden and T cell-to-stroma enrichment (TSE) score are key indicators.
  • The TSE score is highly accurate in predicting which patients will respond to ICI treatment and could be used to select patients for therapy in clinical settings.
View Article and Find Full Text PDF